Please use this identifier to cite or link to this item:
Title: Pancreatic Safety of Sitagliptin in the TECOS Study.
Issue Date: Feb-2017
Citation: Diabetes Care.2017 Feb;(40)2:164-170
Abstract: We evaluated the incidence of acute pancreatitis and pancreatic cancer in patients with type 2 diabetes and cardiovascular disease who were treated with sitagliptin, a dipeptidyl peptidase-4 inhibitor (DPP-4i).
PMID: 27630212
Rights: openAccess
Appears in Collections:Fundaciones e Institutos de Investigación > FIB H. U. Príncipe de Asturias > Artículos

Files in This Item:
File Description SizeFormat 
PMC5864139.pdf1.01 MBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.